Alpha Teknova (TKNO) Current Deferred Revenue (2021 - 2026)
Alpha Teknova's (TKNO) quarterly Current Deferred Revenue came in at $11000.0 in Q1 2026, down 21.43% year-on-year from $14000.0 in Q1 2025, and up 83.33% on a QoQ basis from $6000.0 in Q4 2025.
Alpha Teknova (TKNO) Current Deferred Revenue (2021 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 6 years of Current Deferred Revenue data on file, last reported at $11000.0 in Q1 2026.
- On a quarterly basis, Current Deferred Revenue fell 21.43% year-over-year to $11000.0 in Q1 2026; TTM through Mar 2026 was $11000.0, a 21.43% decrease from a year earlier, with the FY2025 full-year figure at $6000.0, down 80.0% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $11000.0, up from $6000.0 in the prior quarter.
- Over the last five years, Current Deferred Revenue for TKNO reached as high as $1.3 million in Q1 2022 and fell as low as $3000.0 in Q3 2025.
- Historically, Current Deferred Revenue has averaged $188941.2 across 5 years, with a median of $30000.0 in 2024.
- Across the five-year window, Current Deferred Revenue slumped 96.17% in 2023 and surged 87.5% in 2024, its largest moves.
- Year by year, Current Deferred Revenue stood at $198000.0 in 2022, then tumbled by 91.92% to $16000.0 in 2023, then jumped by 87.5% to $30000.0 in 2024, then tumbled by 80.0% to $6000.0 in 2025, then jumped by 83.33% to $11000.0 in 2026.
- Per Business Quant data, the three most recent Current Deferred Revenue figures were $11000.0 in Q1 2026, $6000.0 in Q4 2025, and $3000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 30,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Mar 31, 2024 | 30,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Sep 30, 2023 | 24,000.00 |
| Jun 30, 2023 | 36,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | 198,000.00 |
| Sep 30, 2022 | 487,000.00 |
| Jun 30, 2022 | 941,000.00 |
| Mar 31, 2022 | 1.30 Mn |
| Dec 31, 2021 | 200,000.00 |